NURS 6630
MIDTERM EXAM 3
A+ GRADED
LATEST 2022
WALDEN
UNIVERSITY
1 out of 1 points
When an unstable patient asks why it is necessary to add
medications to his current regimen, the PMHNP’s best response
would be:
Selected C.
Answer: “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
• Question 2
0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin
taking medication again to treat her bipolar depression; she is
breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this
patient?
Selected C.
Answer: Lithium
(Lithobid)
• Question 3
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant
monotherapy for depression. After beginning this medication, the PMHNP
noticed that this client seemed to swing into a hypomanic episode. What can
the PMHNP infer from this behavior change?
Selected A.
Answer: This client may have Bipolar III disorder
• Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?
Selected B.
Answer: “The patient could benefit from an
anticonvulsant.”
• Question 5
,1 out of 1 points
The student inquires about antipsychotic medications. Which
, response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?
Selected B.
Answer: Those that are potent D2 antagonists with 5HT2A
antagonism properties
• Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for
which possible effect?
Selected D.
Answer: All of the
above
• Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication work on?
Selected A.
Answer: dopamine and serotonin
• Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can also
modify genes. How do genes impact this process?
Selected B.
Answer: Changes made to proteins lead to changes in
behavior.
• Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
established history of depression. When meeting with the PMHNP, she
presents with apathy and withdrawn social behavior, and she reports a loss
of joy from enjoyable activities since starting her new medication. What does
the PMHNP infer from this encounter with the client?
Selected C.
Answer: The new medication is blocking D2 receptors in the mesolimbic
system
MIDTERM EXAM 3
A+ GRADED
LATEST 2022
WALDEN
UNIVERSITY
1 out of 1 points
When an unstable patient asks why it is necessary to add
medications to his current regimen, the PMHNP’s best response
would be:
Selected C.
Answer: “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
• Question 2
0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin
taking medication again to treat her bipolar depression; she is
breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this
patient?
Selected C.
Answer: Lithium
(Lithobid)
• Question 3
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant
monotherapy for depression. After beginning this medication, the PMHNP
noticed that this client seemed to swing into a hypomanic episode. What can
the PMHNP infer from this behavior change?
Selected A.
Answer: This client may have Bipolar III disorder
• Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?
Selected B.
Answer: “The patient could benefit from an
anticonvulsant.”
• Question 5
,1 out of 1 points
The student inquires about antipsychotic medications. Which
, response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?
Selected B.
Answer: Those that are potent D2 antagonists with 5HT2A
antagonism properties
• Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for
which possible effect?
Selected D.
Answer: All of the
above
• Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication work on?
Selected A.
Answer: dopamine and serotonin
• Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can also
modify genes. How do genes impact this process?
Selected B.
Answer: Changes made to proteins lead to changes in
behavior.
• Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
established history of depression. When meeting with the PMHNP, she
presents with apathy and withdrawn social behavior, and she reports a loss
of joy from enjoyable activities since starting her new medication. What does
the PMHNP infer from this encounter with the client?
Selected C.
Answer: The new medication is blocking D2 receptors in the mesolimbic
system
